Skip to main content

Yarrow Bioscience, Inc.

YARW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001566044

No open-market purchases or sales by Yarrow Bioscience, Inc. insiders were filed in the last 90 days; 46 institutions reported holding it in 13F filings for Q2 2026, worth $8.79M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Yarrow Bioscience, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of YARW: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders7365−8
Shares18.2M14.5M−3.76M (−20.6%)
Value$64.0M$20.1M−$43.9M (−68.6%)

New holders (8)

Institutions that held Yarrow Bioscience, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to YARW in Q3 2021
InstitutionSharesValue% of portfolio
Virtu Financial LLC108,319$151.0K0.01%
Gsa Capital Partners LLP92,402$128.0K0.01%
ProShare Advisors LLC11,005$15.0K0.00%
Federated Hermes, Inc.2,295$3.00K0.00%
FMR LLC1,500$2.00K0.00%
Migdal Insurance & Financial Holdings Ltd.1,707$2.00K0.00%
Northwestern Mutual Wealth Management Co875$1.00K0.00%
Gerber Kawasaki Wealth & Investment Management75$00.00%

Sold out (16)

Institutions that held Yarrow Bioscience, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.